Trial intelligence / Profile preview

Atropine plus intracameral epinephrine versus topical tropicamide plus phenylephrine for pupil dilation in phacoemulsification

PACTR201608001739424Recruiting

Sponsor
Dar El Oyoun Hospital
Start
Aug 2016
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of atropine, epinephrine, tropicamide and phenylephrine in cataract (2 arms), sponsored by Dar El Oyoun Hospital. Primary endpoint: Dilated pupil size. Started Aug 2016; status: recruiting.

02

Drugs

atropineepinephrinetropicamidephenylephrine
03

Conditions

cataract

Beyond the preview

Go deeper on PACTR201608001739424.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201608001739424.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call